Pathobiology of cervical spondylotic myelopathy

Spyridon K. Karadimas1, George Gatzounis2, Michael G. Fehlings1
1Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada
2Department of Neurosurgery, University of Patras, 26500, Patras, Greece

Tóm tắt

Từ khóa


Tài liệu tham khảo

Kalsi-Ryan S, Karadimas SK, Fehlings MG (2013) Cervical spondylotic myelopathy: the clinical phenomenon and the current pathobiology of an increasingly prevalent and devastating disorder. Neuroscientist 19:409–421

Karadimas SK, Erwin WM, Ely CG et al (2013) Pathophysiology and natural history of cervical spondylotic myelopathy. Spine (Phila Pa 1976) 38:S21–S36

Fehlings MG, Wilson JR, Karadimas SK et al (2013) Clinical evaluation of a neuroprotective drug in patients with cervical spondylotic myelopathy undergoing surgical treatment: design and rationale for the CSM-protect trial. Spine (Phila Pa 1976) 38:S68–S75

Baptiste DC, Fehlings MG (2006) Pathophysiology of cervical myelopathy. Spine J 6:190S–197S

Fehlings MG, Skaf G (1998) A review of the pathophysiology of cervical spondylotic myelopathy with insights for potential novel mechanisms drawn from traumatic spinal cord injury. Spine (Phila Pa 1976) 23:2730–2737

Brain WR, Knight GC, Bull JW (1948) Discussion of rupture of the intervertebral disc in the cervical region. Proc R Soc Med 41:509–516

Mair WG, Druckman R (1953) The pathology of spinal cord lesions and their relation to the clinical features in protrusion of cervical intervertebral discs; a report of four cases. Brain 76:70–91

Taylor AR (1953) Mechanism and treatment of spinal-cord disorders associated with cervical spondylosis. Lancet 1:717–720

Crum B, Mokri B, Fulgham J (2000) Spinal manifestations of vertebral artery dissection. Neurology 55:304–306

Breig A, Turnbull I, Hassler O (1966) Effects of mechanical stresses on the spinal cord in cervical spondylosis. A study on fresh cadaver material. J Neurosurg 25:45–56

Gooding MR, Wilson CB, Hoff JT (1975) Experimental cervical myelopathy. Effects of ischemia and compression of the canine cervical spinal cord. J Neurosurg 43:9–17

Gooding MR, Wilson CB, Hoff JT (1976) Experimental cervical myelopathy: autoradiographic studies of spinal cord blood flow patterns. Surg Neurol 5:233–239

Doppman JL (1975) The mechanism of ischemia in anteroposterior compression of the spinal cord. Invest Radiol 10:543–551

McCormack BM, Weinstein PR (1996) Cervical spondylosis. An update. West J Med 165:43–51

Adams CB, Logue V (1971) Studies in cervical spondylotic myelopathy. II. The movement and contour of the spine in relation to the neural complications of cervical spondylosis. Brain 94:568–586

Strek P, Reron E, Maga P et al (1998) A possible correlation between vertebral artery insufficiency and degenerative changes in the cervical spine. Eur Arch Otorhinolaryngol 255:437–440

Uchida K, Nakajima H, Sato R et al (2009) Cervical spondylotic myelopathy associated with kyphosis or sagittal sigmoid alignment: outcome after anterior or posterior decompression. J Neurosurg Spine 11:521–528

Shimizu K, Nakamura M, Nishikawa Y et al (2005) Spinal kyphosis causes demyelination and neuronal loss in the spinal cord: a new model of kyphotic deformity using juvenile Japanese small game fowls. Spine (Phila Pa 1976) 30:2388–2392

Shamji MF, Ames CP, Smith JS et al (2013) Myelopathy and spinal deformity: relevance of spinal alignment in planning surgical intervention for degenerative cervical myelopathy. Spine (Phila Pa 1976) 38:S147–S148

Kurokawa R, Murata H, Ogino M et al (2011) Altered blood flow distribution in the rat spinal cord under chronic compression. Spine (Phila Pa 1976) 36:1006–1009

Good DC, Couch JR, Wacaser L (1984) “Numb, clumsy hands” and high cervical spondylosis. Surg Neurol 22:285–291

Al-Mefty O, Harkey HL, Marawi I et al (1993) Experimental chronic compressive cervical myelopathy. J Neurosurg 79:550–561

Hoff JNM, Pitts L, Vilnis V, Tuerk K, Lagger R (1977) The role of ischemia in the pathogenesis of cervical spondylotic myelopathy: a review and new microangiopathic evidence. Spine (Phila Pa 1976) 2:100–108

Ono KOH, Tada K, Yamamoto T (1977) Cervical myelopathy secondary to multiple spondylotic protrusions. Spine (Phila Pa 1976) 2:109–125

Ogino H, Tada K, Okada K et al (1983) Canal diameter, anteroposterior compression ratio, and spondylotic myelopathy of the cervical spine. Spine (Phila Pa 1976) 8:1–15

Carlson GD, Warden KE, Barbeau JM et al (1997) Viscoelastic relaxation and regional blood flow response to spinal cord compression and decompression. Spine (Phila Pa 1976) 22:1285–1291

Karadimas SK, Moon E, Yu W, Satkunendrarajah K, Kallitsis JK, Gatzounis G, Fehlings MG (2013) A novel experimental model of cervical spondylotic myelopathy (CSM) to facilitate translational research. neurobiology of disease. Neurobiol Dis 54:43–58

Klironomos G, Karadimas S, Mavrakis A et al (2011) New experimental rabbit animal model for cervical spondylotic myelopathy. Spinal Cord 49:1097–1102

Yu W, Karadimas S, Fehlings MG (2012) Human and animal model evidence supporting a role for Cx3cr1. In: Mediating the inflammatory response in cervical spondylotic myelopathy. Abstract presented at the 2012 Society for Neuroscience Meeting in October, New Orleans, Society of neuroscience

Noble LJ, Wrathall JR (1989) Distribution and time course of protein extravasation in the rat spinal cord after contusive injury. Brain Res 482:57–66

Loy DN, Crawford CH, Darnall JB et al (2002) Temporal progression of angiogenesis and basal lamina deposition after contusive spinal cord injury in the adult rat. J Comp Neurol 445:308–324

Fleming JC, Norenberg MD, Ramsay DA et al (2006) The cellular inflammatory response in human spinal cords after injury. Brain 129:3249–3269

Noble LJ, Donovan F, Igarashi T et al (2002) Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events. J Neurosci 22:7526–7535

Schnell L, Fearn S, Schwab ME et al (1999) Cytokine-induced acute inflammation in the brain and spinal cord. J Neuropathol Exp Neurol 58:245–254

Strbian D, Durukan A, Pitkonen M et al (2008) The blood-brain barrier is continuously open for several weeks following transient focal cerebral ischemia. Neuroscience 153:175–181

Nico B, Ribatti D (2012) Morphofunctional aspects of the blood-brain barrier. Curr Drug Metab 13:50–60

Yu WR, Liu T, Kiehl TR, Fehlings MG (2011) Human neuropathological and animal model evidence supporting a role for Fas-mediated apoptosis and inflammation in cervical spondylotic myelopathy. Brain 134:1277–1292

Harrison JK, Jiang Y, Chen S et al (1998) Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc Natl Acad Sci USA 95:10896–10901

Tarozzo G, Campanella M, Ghiani M et al (2002) Expression of fractalkine and its receptor, CX3CR1, in response to ischaemia-reperfusion brain injury in the rat. Eur J Neurosci 15:1663–1668

Denes A, Ferenczi S, Halasz J et al (2008) Role of CX3CR1 (fractalkine receptor) in brain damage and inflammation induced by focal cerebral ischemia in mouse. J Cereb Blood Flow Metab 28:1707–1721

Fuhrmann M, Bittner T, Jung CK et al (2010) Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer’s disease. Nat Neurosci 13:411–413

Fumagalli S, Perego C, Ortolano F, De Simoni MG (2013) CX3CR1 deficiency induces an early protective inflammatory environment in ischemic mice. Glia 61:827–842

Karadimas SK, Gialeli CH, Klironomos G et al (2010) The role of oligodendrocytes in the molecular pathobiology and potential molecular treatment of cervical spondylotic myelopathy. Curr Med Chem 17:1048–1058

Yu WR, Baptiste DC, Liu T et al (2009) Molecular mechanisms of spinal cord dysfunction and cell death in the spinal hyperostotic mouse: implications for the pathophysiology of human cervical spondylotic myelopathy. Neurobiol Dis 33:149–163

Karadimas SK, Klironomos G, Papachristou DJ et al (2013) Immunohistochemical profile of NF-kappaB/p50, NF-kappaB/p65, MMP-9, MMP-2, and u-PA in experimental cervical spondylotic myelopathy. Spine (Phila Pa 1976) 38:4–10

Karadimas SKME, Fehlings MG (2012) The sodium channel/glutamate blocker riluzole is complementary to decompression in a preclinical experimental model of cervical spondylotic myelopathy (CSM): implications for translational clinical application. Neurosurgery 71:543